ShedRx (Shed) Tirzepatide Review: Cost, Formats & Honest Verdict (2026)

Shed (tryshed.com, formerly marketed at shedrx.com) is a weight-loss platform rather than a single-molecule prescriber, and its standout feature for tirzepatide is choice: compounded injections, GLP-1 liquid drops, and lozenges for people who won't inject, plus a genuine brand Zepbound and Wegovy pathway for anyone who wants the FDA-approved product. Unlimited follow-up appointments and health coaching are included in the membership, and the company backs its program with a published 120-day weight-loss guarantee — an unusual commitment in a category that mostly sells month to month with no promise attached. Every fact here comes from the company's own published program.

What Shed is

Shed positions itself as a broader weight-management platform, not a dedicated single-drug clinic. For tirzepatide specifically it offers four distinct routes to the same molecule: a compounded weekly injection, GLP-1 liquid drops, and GLP-1 lozenges for people who won't self-inject, plus access to the FDA-approved brand products Zepbound and Wegovy for anyone who wants the trial-grade medication rather than a compounded copy. GLP-1 treatment is in all 50 states. Unlimited follow-up appointments and health coaching are folded into the membership rather than sold as an add-on, and the company publishes a 120-day weight-loss guarantee — a specific, time-bound commitment almost nothing else in this category offers.

The brand-vs-compounded question

Two very different products share the name tirzepatide:

• •Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management, obstructive sleep apnea) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
• •Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials. Shed's own compounded-product disclaimer states, and verbatim, that its compounded medications "are FDA-approved and are made by a licensed pharmacy based on a provider's prescription" — worth reading carefully: the underlying molecule is FDA-approved for other formulations, but a compounded preparation itself is not an FDA-approved finished drug product, and Shed does not publicly name the compounding pharmacy that prepares it.

Shed is one of the few platforms in this ranking that lets you choose either side of that line from the same account — compounded, at a lower price, or brand, at a materially higher one. The full legal timeline is in our guide to whether compounded tirzepatide is still legal in 2026.

What Shed costs in 2026

Compounded tirzepatide injections are $299/month month-to-month, falling to $269/month on a six-month plan ("Save $180") and $239/month on a twelve-month plan ("Save $720"). The widely advertised "as low as $239" figure is the twelve-month commitment rate, not the entry price — read the term length before assuming that number applies to you. GLP-1 liquid drops and lozenges are priced separately from the injection, and compounded semaglutide is advertised "as low as $159/month" on the same site, for readers comparing molecules. Brand Zepbound and Wegovy are priced by prescription rather than a flat platform rate; for the branded cash-price benchmark, see our Zepbound cost and savings guide.

How the care model holds up

Shed's strengths are real: four routes to the same molecule (injection, drops, lozenges, or the brand product), unlimited follow-up appointments and health coaching included in the membership rather than billed separately, a published 120-day weight-loss guarantee, and GLP-1 treatment confirmed in all 50 states. The trade-offs are equally real: at $299/month month-to-month it costs roughly twice what a flat-rate compounded competitor like CoreAge Rx charges for the same molecule, and reaching the advertised $239 rate requires a twelve-month commitment paid or billed on that schedule. Its compounded product is not the FDA-approved branded formulation, and the dispensing compounding pharmacy is not publicly named anywhere on the site. As with any GLP-1 program, confirm continuity of care and read the guarantee's exact terms before you commit; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Shed is a strong pick if your priority is choice of format — injection, drops, lozenges, or the FDA-approved brand product, all from one account — plus unlimited coaching and a published guarantee you can hold the company to. The reservations are cost (roughly double a flat-rate compounded competitor unless you commit to twelve months) and an unnamed compounding pharmacy behind the injectable product. If a low flat price matters more than format choice, weigh CoreAge Rx; if you specifically want the needle-free route at a lower entry price, compare Strut Health's sublingual option; and if brand-name access without Shed's format menu is the priority, weigh Synergy Rx's clinician-led approach instead. See our best tirzepatide providers ranking for the full field.